720795Certain Indexes:- Project ADSORClosedGRD Development of PrototypeInnovate UKThis project proposes a novel research apparatus, where none currently exists, to bring both automation and multiple arenas to a novel methodology for Spontaneous Object Recognition (SOR) by collaboration between a UK university and UK scientific instruments company. The apparatus will significantly reduce both the time required and the number of subjects and costs. Results will be scored automatically, removing subjective judgement and facilitating computer-based analysis. Neurological ailments have grown in prevalence, with aging populations inherently susceptible. Development of new therapies requires more efficient, lower cost methodologies, brought to clinical use in shorter times and with greater economy of research funds. Alzheimer’s Disease (AzD) is increasingly prevalent in an aging population, particularly afflicting women. Anxiety disorders (AD) include post-traumatic stress disorder (PTSD) and obsessive–compulsive disorder (OCD). Research of episodic memory (EM) has an emerging role in AzD and AD using SOR for investigation of brain function and Phase 0 pre-clinical studies for medicines. Scientific experimentation needs to be robust and reproducible, however pharmaceutical companies (Pharma) have reduced investment in research for neurological therapies due problems of irreproducibility of data in problematic methodologies, impairing the drug discovery process. SOR has been extensively published in academic research, however the prevailing current methodology has several disadvantages:- The procedure is slow, manual in operation with one procedure per day, is time consuming and costly, with no standardisation of apparatus or procedure, results is also problematic and can typically show significant variance, often to the extent of a lack of repeatability. The prevailing methodology prevents investigation of some potentially useful novel compounds due to their short time of stability.